Suchergebnisse - "Kidney Neoplasms diagnosis"

  1. 1
  2. 2

    Quelle: Clin Cancer Res
    Lyskjær, I, Iisager, L, Axelsen, C T, Nielsen, T K, Dyrskjøt, L & Fristrup, N 2024, ' Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic ', Clinical Cancer Research, vol. 30, no. 4, pp. 663-672 . https://doi.org/10.1158/1078-0432.CCR-23-1892
    Lyskjær, I, Iisager, L, Axelsen, C T, Nielsen, T K, Dyrskjøt, L & Fristrup, N 2024, 'Management of renal cell carcinoma : promising biomarkers and the challenges to reach the clinic', Clinical Cancer Research, vol. 30, no. 4, pp. 663-672. https://doi.org/10.1158/1078-0432.CCR-23-1892

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Weitere Verfasser: Katims, Andrew B Say, Rollin Derweesh, Ithaar et al.

    Quelle: Journal of Urology. 206:568-576

    Dateibeschreibung: application/pdf

  10. 10

    Quelle: Eur J Hum Genet
    Geilswijk, M, Genuardi, M, Woodward, E R, Nightingale, K, Huber, J, Madsen, M G, Liekelema-van der Heij, D, Lisseman, I, Marlé-Ballangé, J, McCarthy, C, Menko, F H, Moorselaar, R J A V, Radzikowska, E, Richard, S, Rajan, N, Sommerlund, M, Wetscherek, M T A, di Donato, N, Maher, E R & Brunet, J 2024, 'ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndrome', European Journal of Human Genetics, vol. 32, no. 12. https://doi.org/10.1038/s41431-024-01671-2
    Geilswijk, M, Genuardi, M, Woodward, E R, Nightingale, K, Huber, J, Madsen, M G, Liekelema-van der Heij, D, Lisseman, I, Marlé-Ballangé, J, McCarthy, C, Menko, F H, Moorselaar, R J A V, Radzikowska, E, Richard, S, Rajan, N, Sommerlund, M, Wetscherek, M T A, Di Donato, N, Maher, E R & Brunet, J 2024, 'ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndrome', European Journal of Human Genetics, vol. 32, no. 12, pp. 1542-1550. https://doi.org/10.1038/s41431-024-01671-2

    Dateibeschreibung: application/pdf; text/xml

  11. 11

    Quelle: BMC Urol
    BMC Urology, Vol 23, Iss 1, Pp 1-8 (2023)
    Azawi, N, Mosholt, K S S, Fryd, N D, Lund, L, Brignone, J I, Hvid, N, Wulf-Johansson, H, Pedersen, O B V, Saekmose, S G & Dabestani, S 2023, 'suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma', BMC urology, vol. 23, no. 1, 168. https://doi.org/10.1186/s12894-023-01337-z
    Azawi, N, Mosholt, K S S, Fryd, N D, Lund, L, Brignone, J I, Hvid, N, Wulf-Johansson, H, Pedersen, O B V, Saekmose, S G & Dabestani, S 2023, ' suPARnostic : an advanced predictive tool for detecting recurrence in renal cell carcinoma ', BMC Urology, vol. 23, no. 1, 168 . https://doi.org/10.1186/s12894-023-01337-z
    Azawi, N, Mosholt, K S S, Fryd, N D, Lund, L, Brignone, J I, Hvid, N, Wulf-Johansson, H, Pedersen, O B V, Saekmose, S G & Dabestani, S 2023, 'suPARnostic : an advanced predictive tool for detecting recurrence in renal cell carcinoma', BMC Urology, vol. 23, no. 1, 168. https://doi.org/10.1186/s12894-023-01337-z

    Dateibeschreibung: application/pdf

  12. 12

    Quelle: Oncogene

    Dateibeschreibung: application/pdf

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20